Docetaxel‐induced interstitial lung disease among patients with breast cancer: a case series and review of literature

Taxane‐induced pneumotoxicity is rare. However, 1–5% of patients taking docetaxel may develop severe pneumotoxicity. This has been limited to case reports in the literature. We report seven breast cancer patients who developed docetaxel‐induced diffuse parenchymal lung disease (DPLD) of an organizin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hettiarachchi, Sanjeewa Malinda, Thilakaratne, Dilanka, Dharmasena, Dawpadee, Rathnapala, Amila, Abeysinghe, Prasad, Perera, Eshanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200505/
https://www.ncbi.nlm.nih.gov/pubmed/34136263
http://dx.doi.org/10.1002/rcr2.802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200505/
https://www.ncbi.nlm.nih.gov/pubmed/34136263
http://dx.doi.org/10.1002/rcr2.802

Ejemplares similares